Clarametyx Biosciences Awarded Up to $14.2 Million From Carb-x to Accelerate Novel Immune-enabling Technology to Combat Persistent Bacterial Infections
Funding agreement fuels development of platform targeting universal structure…
Data Published in Ebiomedicine Validates Novel Scientific Approach that Disarms Bacterial Defenses to Treat or Prevent Life-threatening Infections
Approach effectively degrades bacterial protective shields to enable immune or…
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Renowned Columbus-based leaders and scientific innovators to develop novel…